Brain insulin resistance linked Alzheimer’s and Parkinson’s disease pathology: An undying implication of epigenetic and autophagy modulation

Avila-Muñoz E, Arias C (2014) When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer’s disease. Ageing Res Rev 18:29–40

Article  PubMed  Google Scholar 

Avruch J, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D, Zhang XF (2001) Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog Horm Res 56:127–155

Article  CAS  PubMed  Google Scholar 

Axelsen PH, Komatsu H, Murray IVJ (2011) Oxidative stress and cell membranes in the pathogenesis of Alzheimer’s disease. Physiology 26:54–69

Article  CAS  PubMed  Google Scholar 

Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21:381–395. https://doi.org/10.1038/cr.2011.22

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bassil F, Canron M, Vital A, Bezard E, Fernagut P, Meissner W (2015) Brain insulin resistance in Parkinson’s disease and Multiple System Atrophy

Batista AF, Forny-Germano L, Clarke JR, Silva NME, Brito-MoreiraJ, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF (2018) The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer’s disease. J Pathol 245:85–100

Batarseh YS, Duong Q-V, Mousa YM, Al Rihani SB, Elfakhri K, Kaddoumi A (2016) Amyloid-β and astrocytes interplay in amyloid-β related disorders. Int J Mol Sci 17:338

Article  PubMed  PubMed Central  Google Scholar 

Beauquis J, Pavia P, Pomilio C, Vinuesa A, Podlutskaya N, Galvan V, Saravia F (2013) Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer’s disease. Exp Neurol 239:28–37

Article  CAS  PubMed  Google Scholar 

Berlanga-Acosta J, Guillén-Nieto G, Rodríguez-Rodríguez N, Bringas-Vega ML, García-del-Barco-Herrera D, Berlanga-Saez JO, García-Ojalvo A, Valdés-Sosa MJ, Valdés-Sosa PA (2020) Insulin resistance at the crossroad of Alzheimer disease pathology: a review. Front Endocrinol (lausanne) 11:1–22. https://doi.org/10.3389/fendo.2020.560375

Article  Google Scholar 

Blandino-Rosano M, Barbaresso R, Jimenez-Palomares M, Bozadjieva N, Werneck-de-Castro JP, Hatanaka M, Mirmira RG, Sonenberg N, Liu M, Rüegg MA (2017) Others, Loss of mTORC1 signalling impairs β-cell homeostasis and insulin processing. Nat Commun 8:1–15

Article  Google Scholar 

Boutouja F, Stiehm CM, Platta HW (2019) mTOR: a cellular regulator interface in health and disease. Cells 8:18

Article  CAS  PubMed  PubMed Central  Google Scholar 

Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR. (2000) isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33:95–130

Caccamo A, De Pinto V, Messina A, Branca C, Oddo S (2014) Genetic reduction of mammalian target of rapamycin ameliorates Alzheimer’s disease-like cognitive and pathological deficits by restoring hippocampal gene expression signature. J Neurosci 34:7988–7998

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cacquevel M, Lebeurrier N, Cheenne S, Vivien D (2004) Cytokines Neuroinflammation Alzheimer’s Dis. Curr Drug Targets 5:529–534

Article  CAS  PubMed  Google Scholar 

Cao DJ, Wang ZV, Battiprolu PK, Jiang N, Morales CR, Kong Y, Rothermel BA, Gillette TG, Hill JA (2011) Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci 108:4123–4128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carnevalli LS, Masuda K, Frigerio F, Le Bacquer O, Um SH, Gandin V, Topisirovic I, Sonenberg N, Thomas G, Kozma SC (2010) S6K1 plays a critical role in early adipocyte differentiation. Dev Cell 18:763–774

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carvalho C, Santos MS, Oliveira CR, Moreira PI, (2015) Alzheimer’s disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers. Biochim Biophys Acta (BBA)-Molecular Basis Dis 1852:1665–1675

Chen J, Yu S, Fu Y, Li X (2014) Synaptic proteins and receptors defects in autism spectrum disorders. Front Cell Neurosci 8:276

Article  PubMed  PubMed Central  Google Scholar 

Chen X, Li Y, Wang C, Tang Y, Mok S-A, Tsai RM, Rojas JC, Karydas A, Miller BL, Boxer AL (2020) Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy. Mol Neurodegener 15:1–19

Article  Google Scholar 

Clarke JR, Silva NME, Figueiredo CP, Frozza RL, Ledo JH, Beckman D, Katashima CK, Razolli D, Carvalho BM, Frazão R (2015) Alzheimer-associated Aβ oligomers impact the central nervous system to induce peripheral metabolic deregulation. EMBO Mol Med 7:190–210

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coates DR, Chin JM, Chung STL (2011) 基因的改变NIH public access. Bone 23:1–7. https://doi.org/10.1038/nature12313.The

Article  Google Scholar 

Cook DG, Leverenz JB, McMillan PJ, Kulstad JJ, Ericksen S, Roth RA, Schellenberg GD, Jin L-W, Kovacina KS, Craft S (2003) Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer’s disease is associated with the apolipoprotein E-ε4 allele. Am J Pathol 162:313–319

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, Beal MF, Bergersen LH, Brinton RD, de la Monte S, Eckert A, Harvey J, Jeggo R, Jhamandas JH, Kann O, la Cour CM, Martin WF, Mithieux G, Moreira PI, Murphy MP, Nave KA, Nuriel T, Oliet SHR, Saudou F, Mattson MP, Swerdlow RH, Millan MJ (2020) Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov 19:609–633. https://doi.org/10.1038/s41573-020-0072-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P (2007) mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex. Nature 450:736–740

Article  CAS  PubMed  Google Scholar 

De Felice FG (2013) Connecting type 2 diabetes to Alzheimer’s disease. Expert Rev Neurother 13:1297–1299

Article  PubMed  Google Scholar 

De Felice FG, Lourenco MV, Ferreira ST (2014) How does brain insulin resistance develop in Alzheimer’s disease? Alzheimer’s Dement. 10:S26–S32

Article  Google Scholar 

Ding H, Dolan PJ, Johnson GVW (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J Neurochem 106:2119–2130

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dolan PJ, Johnson GVW (2010) A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J Biol Chem 285:21978–21987

Article  CAS  PubMed  PubMed Central  Google Scholar 

Donmez G, Arun A, Chung C-Y, McLean PJ, Lindquist S, Guarente L (2012) SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci 32:124–132

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, Placido A, Santos MS, Oliveira CR, Moreira PI (2013) Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta Mol Basis Dis 1832:527–541

Duclot F, Meffre J, Jacquet C, Gongora C, Maurice T (2010) Mice knock out for the histone acetyltransferase p300/CREB binding protein-associated factor develop a resistance to amyloid toxicity. Neuroscience 167:850–863

Article  CAS  PubMed  Google Scholar 

Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S (2010) others, Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39:171–183

Article  PubMed  PubMed Central  Google Scholar 

El Khoury N, Gratuze M, Papon M-A, Bretteville A, Planel E (2014) Insulin dysfunction and Tau pathology. Front Cell Neurosci 8:22

Article  PubMed  PubMed Central  Google Scholar 

Erion DM, Shulman GI (2010) Diacylglycerol-mediated insulin resistance. Nat Med 16:400–402

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fajans SS, Bell GI (2011) MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 34:1878–1884

Article  PubMed  PubMed Central  Google Scholar 

Fang EF, Hou Y, Palikaras K, Adriaanse BA, Kerr JS, Yang B, Lautrup S, Hasan-Olive MM, Caponio D, Dan X (2019) Others, Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci 22:401–412

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fehm HL, Kern W, Peters A (2006) The selfish brain: competition for energy resources. Prog Brain Res 153:129–140

Article  CAS  PubMed  Google Scholar 

Feng Y, He D, Yao Z, Klionsky DJ (2014) The machinery of macroautophagy. Cell Res 24:24–41

Article  CAS  PubMed  Google Scholar 

Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG (2018) Insulin resistance in Alzheimer’s disease. Front Neurosci 12:1–11. https://doi.org/10.3389/fnins.2018.00830

Article  Google Scholar 

Füllgrabe J, Klionsky DJ, Joseph B (2013) Histone post-translational modifications regulate autophagy flux and outcome. Autophagy 9:1621–1623. https://doi.org/10.4161/auto.25803

Article  PubMed 

留言 (0)

沒有登入
gif